These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 15365307)

  • 1. Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers.
    Drobes DJ; Anton RF; Thomas SE; Voronin K
    Alcohol Clin Exp Res; 2004 Sep; 28(9):1362-70. PubMed ID: 15365307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical laboratory paradigm for evaluating medication effects on alcohol consumption: naltrexone and nalmefene.
    Drobes DJ; Anton RF; Thomas SE; Voronin K
    Neuropsychopharmacology; 2003 Apr; 28(4):755-64. PubMed ID: 12655322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking.
    Anton RF; Drobes DJ; Voronin K; Durazo-Avizu R; Moak D
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):32-40. PubMed ID: 14722705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of alcohol availability, access to alcohol, and naltrexone on self-reported craving and patterns of drinking in response to an alcohol-cue availability procedure.
    Kruse MI; Radnovich AJ; Kalapatapu RK; Mehdiyoun N; Chambers RA; Davidson D
    J Stud Alcohol Drugs; 2012 Mar; 73(2):205-15. PubMed ID: 22333328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nalmefene. Alcohol dependence: no advance.
    Prescrire Int; 2014 Jun; 23(150):150-2. PubMed ID: 25121147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nalmefene attenuates neural alcohol cue-reactivity in the ventral striatum and subjective alcohol craving in patients with alcohol use disorder.
    Karl D; Bumb JM; Bach P; Dinter C; Koopmann A; Hermann D; Mann K; Kiefer F; Vollstädt-Klein S
    Psychopharmacology (Berl); 2021 Aug; 238(8):2179-2189. PubMed ID: 33846866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
    O'Malley SS; Krishnan-Sarin S; Farren C; Sinha R; Kreek MJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):19-29. PubMed ID: 11862370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of naltrexone on neural and subjective response to alcohol in treatment-seeking alcohol-dependent patients.
    Spagnolo PA; Ramchandani VA; Schwandt ML; Zhang L; Blaine SK; Usala JM; Diamond KA; Phillips MJ; George DT; Momenan R; Heilig M
    Alcohol Clin Exp Res; 2014 Dec; 38(12):3024-32. PubMed ID: 25581657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-Analysis.
    Soyka M; Friede M; Schnitker J
    Pharmacopsychiatry; 2016 Mar; 49(2):66-75. PubMed ID: 26845589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
    Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
    Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.
    Ray LA; Hutchison KE
    Arch Gen Psychiatry; 2007 Sep; 64(9):1069-77. PubMed ID: 17768272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence.
    Mason BJ; Ritvo EC; Morgan RO; Salvato FR; Goldberg G; Welch B; Mantero-Atienza E
    Alcohol Clin Exp Res; 1994 Oct; 18(5):1162-7. PubMed ID: 7847600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.
    Anton RF; Voronin KK; Randall PK; Myrick H; Tiffany A
    Alcohol Clin Exp Res; 2012 Nov; 36(11):2000-7. PubMed ID: 22551036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
    Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who Receives Nalmefene and How Does It Work in the Real World? A Single-Arm, Phase IV Study of Nalmefene in Alcohol Dependent Outpatients: Baseline and 1-Month Results.
    Barrio P; Ortega L; Guardia J; Roncero C; Yuguero L; Gual A
    Clin Drug Investig; 2018 Feb; 38(2):147-155. PubMed ID: 29080208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience of a "slip" among alcoholics treated with naltrexone or placebo.
    O'Malley SS; Jaffe AJ; Rode S; Rounsaville BJ
    Am J Psychiatry; 1996 Feb; 153(2):281-3. PubMed ID: 8561215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking.
    Krishnan-Sarin S; Krystal JH; Shi J; Pittman B; O'Malley SS
    Biol Psychiatry; 2007 Sep; 62(6):694-7. PubMed ID: 17336941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distress Tolerance and Craving for Cigarettes Among Heavy Drinking Smokers.
    Lim AC; Roche DJO; Ray LA
    J Stud Alcohol Drugs; 2018 Nov; 79(6):918-928. PubMed ID: 30573023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium oxybate plus nalmefene for the treatment of alcohol use disorder: A case series.
    Caputo F; Maremmani AG; Addolorato G; Domenicali M; Zoli G; D'Amore A; Maremmani I; Bernardi M
    J Psychopharmacol; 2016 Apr; 30(4):402-9. PubMed ID: 26860331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence.
    Anton RF; Pettinati H; Zweben A; Kranzler HR; Johnson B; Bohn MJ; McCaul ME; Anthenelli R; Salloum I; Galloway G; Garbutt J; Swift R; Gastfriend D; Kallio A; Karhuvaara S
    J Clin Psychopharmacol; 2004 Aug; 24(4):421-8. PubMed ID: 15232334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.